Skip to main content
Log in

Successful matched unrelated BMT for secondary AML which developed simultaneously with relapsed Hodgkin's lymphoma

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J et al. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2003; 21: 3440–3446.

    Article  Google Scholar 

  2. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA . Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76–81.

    Article  CAS  Google Scholar 

  3. van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12: 312–325.

    Article  CAS  Google Scholar 

  4. van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994; 12: 1063–1073.

    Article  CAS  Google Scholar 

  5. Anderson JE, Gooley TA, Schoch G, Anasetti C, Bensinger WI, Clift RA et al. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. Blood 1997; 89: 2578–2585.

    CAS  PubMed  Google Scholar 

  6. Witherspoon RP, Deeg HJ, Storer B, Anasetti C, Storb R, Appelbaum FR . Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia. J Clin Oncol 2001; 19: 2134–2141.

    Article  CAS  Google Scholar 

  7. Kroger N, Shimoni A, Zabelina T, Schieder H, Panse J, Ayuk F et al. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS). Bone Marrow Transplant 2006; 37: 339–344.

    Article  CAS  Google Scholar 

  8. Munker R, Grutzner S, Hiller E, Aydemir U, Enne W, Dietzfelbinger H et al. Second malignancies after Hodgkin's disease: the Munich experience. Ann Hematol 1999; 78: 544–554.

    Article  CAS  Google Scholar 

  9. Akpek G, Ambinder RF, Piantadosi S, Abrams RA, Brodsky RA, Vogelsang GB et al. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol 2001; 19: 4314–4321.

    Article  CAS  Google Scholar 

  10. Peggs KS, Hunter A, Chopra R, Parker A, Mahendra P, Milligan D et al. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet 2005; 365: 1934–1941.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Ms Megumi Naito for her technical assistance in chimerism analysis and Ms Kimie Shibuya for her secretarial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Ohwada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohwada, C., Nakaseko, C., Tanaka, H. et al. Successful matched unrelated BMT for secondary AML which developed simultaneously with relapsed Hodgkin's lymphoma. Bone Marrow Transplant 39, 569–570 (2007). https://doi.org/10.1038/sj.bmt.1705642

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705642

  • Springer Nature Limited

Navigation